Cadherin-11、SMOC2与PEDF是有前景的肾脏纤维化无创生物标志物
研究探索了CDH11、SMOC2、PEDF、MGP和TSP2五种候选肾脏纤维化生物标志物,利用单细胞/单核RNA测序确认成纤维细胞特异性表达,并在两个独立CKD前瞻队列中检测血浆和尿液水平。多变量调整后,血浆CDH11、SMOC2、PEDF及尿CDH11、PEDF与肾小管间质纤维化严重程度显著相关;血浆和尿SMOC2及尿CDH11与进展至终末期肾病独立相关。
要点
- 血浆CDH11、SMOC2、PEDF和尿CDH11、PEDF与肾小管间质纤维化严重程度相关。
- 血浆和尿SMOC2及尿CDH11与进展至终末期肾病独立相关。
- 尿PEDF在西雅图肾脏研究中与ESKD相关,波士顿队列中信号类似但未达统计学显著。
核心结论
- CDH11、SMOC2和PEDF是有前景的肾脏纤维化无创生物标志物。
研究设计与样本
- 探索单细胞和单核RNA测序数据集中纤维化 rodent 模型和人类CKD的基因表达谱,并开发Luminex检测方法。
- 在波士顿肾脏活检队列(活检确认的半定量肾脏纤维化评估)和西雅图肾脏研究(常见CKD形式患者)两个独立前瞻队列中测量血浆和尿液生物标志物水平。
主要发现
- 单细胞/单核RNA测序数据确认生物标志物基因在成纤维细胞中细胞特异性表达。
- 多变量调整后,波士顿肾脏活检队列中较高水平的血浆CDH11、SMOC2、PEDF和尿CDH11、PEDF与肾小管间质纤维化严重程度增加显著相关。
- 两个队列中,较高水平的血浆和尿SMOC2及尿CDH11与进展至终末期肾病独立相关。
- 西雅图肾脏研究中较高水平尿PEDF与终末期肾病相关,波士顿肾脏活检队列中信号类似但接近未达统计学显著性。
临床怎么用
- 可考虑将血浆CDH11、SMOC2、PEDF和尿CDH11、PEDF作为无创评估肾脏纤维化严重程度的候选生物标志物。
- 可考虑将血浆和尿SMOC2及尿CDH11用于CKD患者进展至终末期肾病的风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Kidney fibrosis constitutes the shared final pathway of nearly all chronic nephropathies, but biomarkers for the non-invasive assessment of kidney fibrosis are currently not available. To address this, we characterize five candidate biomarkers of kidney fibrosis: Cadherin-11 (CDH11), Sparc-related modular calcium binding protein-2 (SMOC2), Pigment epithelium-derived factor (PEDF), Matrix-Gla protein, and Thrombospondin-2. Gene expression profiles in single-cell and single-nucleus RNA-sequencing (sc/snRNA-seq) datasets from rodent models of fibrosis and human chronic kidney disease (CKD) were explored, and Luminex-based assays for each biomarker were developed. Plasma and urine biomarker levels were measured using independent prospective cohorts of CKD: the Boston Kidney Biopsy Cohort, a cohort of individuals with biopsy-confirmed semiquantitative assessment of kidney fibrosis, and the Seattle Kidney Study, a cohort of patients with common forms of CKD. Ordinal logistic regression and Cox proportional hazards regression models were used to test associations of biomarkers with interstitial fibrosis and tubular atrophy and progression to end-stage kidney disease and death, respectively. Sc/snRNA-seq data confirmed cell-specific expression of biomarker genes in fibroblasts. After multivariable adjustment, higher levels of plasma CDH11, SMOC2, and PEDF and urinary CDH11 and PEDF were significantly associated with increasing severity of interstitial fibrosis and tubular atrophy in the Boston Kidney Biopsy Cohort. In both cohorts, higher levels of plasma and urinary SMOC2 and urinary CDH11 were independently associated with progression to end-stage kidney disease. Higher levels of urinary PEDF associated with end-stage kidney disease in the Seattle Kidney Study, with a similar signal in the Boston Kidney Biopsy Cohort, although the latter narrowly missed statistical significance. Thus, we identified CDH11, SMOC2, and PEDF as promising non-invasive biomarkers of kidney fibrosis.
引用
- Schmidt IM, Colona MR, Kestenbaum BR, et al. Cadherin-11, Sparc-related modular calcium binding protein-2, and Pigment epithelium-derived factor are promising non-invasive biomarkers of kidney fibrosis. Kidney Int. 2021. PMID: 34051265. doi:10.1016/j.kint.2021.04.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。